Keros Therapeutics (KROS) EBT Margin (2019 - 2025)
Keros Therapeutics posted quarterly EBT Margin of 4328.42% for Q4 2025, down 1332960.0% year-on-year from N/an in Q4 2024, and down 6992.37% on a QoQ basis from 61.03% in Q3 2025.
Keros Therapeutics (KROS) has 6 years of EBT Margin data on file, last reported at 4328.42% in Q4 2025.
- For the quarter ending Q4 2025, EBT Margin fell 1332960.0% year-over-year to 4328.42%; the trailing twelve-month figure through Dec 2025 stood at 37.62% (down 15583988.0% YoY), and the FY2025 full-year result was 37.65%, changed N/A from the prior year.
- EBT Margin for Q4 2025 stood at 4328.42%, down from 61.03% in the prior quarter.
- Across five years, EBT Margin topped out at 9001.18% in Q4 2024 and bottomed at 541000.0% in Q3 2023.
- The 5-year median for EBT Margin is 181.19% (2025), against an average of 54401.17%.
- The widest annual swing landed in 2024, when EBT Margin soared 52735155 bps; it then tumbled 1332960 bps in 2025.
- A 5-year view of EBT Margin shows it stood at 27.6% in 2021, then tumbled by 387 bps to 134.37% in 2022, then slumped by 24077 bps to 32486.01% in 2023, then jumped by 128 bps to 9001.18% in 2024, then tumbled by 148 bps to 4328.42% in 2025.
- The last three EBT Margin figures came in at 4328.42% (Q4 2025), 61.03% (Q3 2025), and 181.19% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.40% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 41.95% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.05% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 18.99% |
| 10 | Keros Therapeutics | 403.85 Mn | 116.45 Mn | - | -4,328.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4,328.42% |
| Sep 30, 2025 | -61.03% |
| Jun 30, 2025 | -181.19% |
| Mar 31, 2025 | 75.03% |
| Dec 31, 2024 | 9,001.18% |
| Sep 30, 2024 | -13,648.45% |
| Dec 31, 2023 | -32,486.01% |
| Sep 30, 2023 | -541,000.00% |
| Mar 31, 2022 | -134.37% |
| Dec 31, 2021 | -27.60% |
| Jun 30, 2021 | -15,622.00% |
| Dec 31, 2019 | -110.04% |
| Sep 30, 2019 | -141.96% |
| Jun 30, 2019 | -114.12% |
| Mar 31, 2019 | -127.32% |